Oncological outcomes of microscopic residual tumor after curative intended surgery in adenocarcinoma of esophagogastric junction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220721004

Enrollment

420

Registered

2022-07-21

Start date

2005-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of esophagogastric junction Adenocarcinoma of stomach Resection category Microscopic residual tumor Oncological outcomes Adenocarcinoma of esophagogastric junction Adenocarcinoma of stomach Resection category Microscopic residual tumor Oncological outcomes

Interventions

R0 resection,R1 resection

Treatment,Treatment

Non-residual group,Residual group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with adenocarcinoma of esophagogastric junction and stomach Underwent curative intended surgery

Exclusion criteria

Exclusion criteria: R2 resection Neoadjuvant chemotherapy

Design outcomes

Primary

Measure	Time frame
5 year over all survival date of surgery to dead year	—

Secondary

Measure	Time frame
3 year disease free survival date of surgery to recurrence year	—

Countries

Thailand

Contacts

Public Contactthammawat Parakonthun

Faculty of Medicine Siriraj Hospital

t.parakonthun@gmail.com024198005

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026